ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
4D Pharma PLC

4D Pharma PLC (LBPS)

1.65
0.00
(0.00%)
Closed 19 November 8:00AM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.65
Bid
1.82
Offer
1.57
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
1.65
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

LBPS Latest News

4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today...

Update on Suspension of Trading

4D pharma plc (AIM: DDDD, Nasdaq: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, provides an...

4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

- Study to assess safety of MRx0518 with BAVENCIO and effect on progression-free survival at 6 months - Study sites are open for patient enrolment 4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a...

4D pharma to Present at the H.C. Wainwright Global Investment Conference

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today...

4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today...

4D pharma Reports Full Year 2021 Financial Results, Operational Highlights, and Guidance for Key Milestones in 2022

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today reported...

4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab) for the Treatment of Renal Cell Carcinoma

- Primary Efficacy Endpoint Met Early in Renal Cell Carcinoma Group in Part B of Study - Company to Host Conference Call and Webcast Today March 23, 10:00 am EST (2:00 pm GMT) 4D pharma plc...

4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today...

4D pharma Announces FDA Clearance of IND Application for Live Biotherapeutics MRx0005 and MRx0029 for the Treatment of Parkinson’s Disease

- IND clearance marks the expansion of 4D pharma’s clinical-stage pipeline of single strain Live Biotherapeutics into neurology - First US FDA IND clearance for a Live Biotherapeutic for...

4D pharma Announces Additional Positive Data From Part A of the Phase I/II Trial Of MRx-4DP0004 For the Treatment of Asthma

- Part A of the trial achieved the primary endpoint of safety and tolerability - Multiple secondary endpoints show positive trends in improving asthma control, supporting progression into Part B...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HCWBHCW Biologics Inc
US$ 1.235
(319.21%)
511.7M
APLMApollomics Inc
US$ 0.1922
(100.42%)
1.68B
SINTSiNtx Technologies Inc
US$ 3.18
(55.88%)
52.01M
ACRSAclaris Therapeutics Inc
US$ 3.16
(54.15%)
30.65M
JWELJowell Global Ltd
US$ 2.8358
(45.43%)
15.45M
QMMMQMMM Holdings Limited
US$ 1.73
(-76.40%)
6.14M
CMAXCareMax Inc
US$ 0.87
(-48.21%)
838.95k
NGNENeurogene Inc
US$ 19.82
(-42.58%)
2M
DWTXDogwood Therapeutics Inc
US$ 1.85
(-37.71%)
143.85k
SGDSafe and Green Development Corporation
US$ 1.68
(-36.84%)
489.76k
APLMApollomics Inc
US$ 0.1922
(100.42%)
1.68B
HCWBHCW Biologics Inc
US$ 1.235
(319.21%)
511.7M
ELABElevai Labs Inc
US$ 0.0225
(1.81%)
290.23M
NVDANVIDIA Corporation
US$ 140.15
(-1.29%)
222.24M
SMCISuper Micro Computer Inc
US$ 21.54
(15.93%)
198.08M

Discussion

View Full Feed
chereb19 chereb19 3 minutes ago
Must hurt knowing they can raise at a premium to their share price.
Under old management this would have been toxic funding at a huge discount.

The doc cleared house just in time.
RDGL
jog49 jog49 5 minutes ago
"Any hints of a new tay secretary or the FHFA head can send this flying beyond 4. Why is no one talking abt FHFA head yet? Probably too low on the priority list I assume, or have someone in mind already"

Did you consider that there may be no need for a FHFA head because there will be
FNMA
Researchfyi Researchfyi 10 minutes ago
I raised this question before. I always thought LL paid $63 million for 405 million common unrestricted shares per each PR and filled documents. How the heck did these shares become restricted stock? Restricted stock is not bought. They are granted. Restricted stock normally do not have voting right
LQMT
Hoskuld Hoskuld 10 minutes ago
Let's see them run a program that conforms with regulatory expectations first. Just one time.
AVXL
dinogreeves dinogreeves 13 minutes ago
Predicting SMCI will have 60-75 thousand watchers on Stocktwits between April and June, that is actually when the fun will start to 200 dollars.
SMCI
gitreal gitreal 13 minutes ago
this is a very honest and serious gold producing company

That's pretty damn funny!

I have tracked a couple dozen fake mining companies over the last dozen years here on Ihub and other social media. They were all confirmed to be scams, sooner or later. NBRI is an ob
NBRI
Bountiful_Harvest Bountiful_Harvest 15 minutes ago
That's a good find that a lot of folks don't know about yet. I posted the China version last night on Pistol Petes board, which very few read.

You hit the nail on the head regarding the 8k,

That paragraph, which is NOT included in the PR but in the 8-K (the one that mat
SMCI
carlson carlson 17 minutes ago
Isn't that going to make the stock go UP?
NBRI
dinogreeves dinogreeves 21 minutes ago
50 dollars slow grind all the way to 200 dollars in due time. I feel like Hindenburg Rotisserie.
SMCI
Viking61 Viking61 25 minutes ago
Paulson took himself out of consideration for the Treasury job.
FNMA
Jagman5 Jagman5 25 minutes ago
You then go on, once you can afford it, to put up additional facilities.

$BIOF
BIOF
againstallodds againstallodds 26 minutes ago
We can see $20K/month stock promo in action

That’s the JarHead social media promo blitz and trade volume manipulation
NBRI
Tesla Trillionaire Tesla Trillionaire 26 minutes ago
style="caret-color: rgb(23, 23, 23); color: rgba(23, 23, 23, 1); font-family: "Helvetica Neue", BlinkMacSystemFont, -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; background-color: rgba(255, 255, 255, 1)"Elon Musk's bet on the incoming Trump administration is starting to pay off ha
TSLA
Jagman5 Jagman5 28 minutes ago
Nah. How big of a facility are you envisioning? Having been involved in a build-out like this, another mil should do it.

$BIOF
BIOF
nowwhat2 nowwhat2 28 minutes ago
Interesting.......

https://investorshub.advfn.com/uimage/uploads/2024/11/19/ritecXLM_111111_18_15d10PM_YIKES_INTEREST.jpg
XLMUSD
skitahoe skitahoe 31 minutes ago
I believe LP won't say anything until she's certain it will happen. Hopefully they're much closer than some believe, mostly bashers who put it in 2026, or beyond.

I believe it won't take long after approval that UK demand exceeds what they can make manually. Hopefully approving the
NWBO
carlson carlson 33 minutes ago
What is wrong with you? Not enough attention?
NBRI
dfsasdfasddsfds dfsasdfasddsfds 34 minutes ago
https://www.linkedin.com/pulse/roblox-redeem-promo-codes-10000-free-robux-verified-vdgbf

https
dfsasdfasddsfds dfsasdfasddsfds 35 minutes ago
https://www.linkedin.com/pulse/promo-code-gives-free-robux-real-instant-roblox-nv9ef

https:
dfsasdfasddsfds dfsasdfasddsfds 36 minutes ago
dsfafdadf dsfadsf dasfsd
GO4AWILDRIDE GO4AWILDRIDE 37 minutes ago
Colin Petersen Dies: Bee Gees' Original Drummer On Many Classic Hits Was 78.

https://www.msn.com/en-us/music/news/colin-petersen-dies-bee-gees-original-drummer-on-many-classic-hits-was-78/ar-AA1ukaKd?ocid=msedgntp&pc=HCTS&cvid=8d5555d828b546859f56cc265a0c6003&ei=114

dinogreeves dinogreeves 37 minutes ago
https://www.cityam.com/bdo-wins-biggest-international-audit-client-replacing-big-four-firm-kpmg/
SMCI